Skip to site menu Skip to page content

Optimising Pharmaceutical Products Using Formulation Science, Tablets & Capsules

By Patheon

By Kwok Chow, PhD, and Mark J Kontny, PhD

Approval of new drug products that treat unmet medical needs held steady or declined over the last decade.

Meanwhile, pharma companies continue to consolidate, R&D budgets continue to decline, and the cost of conducting late-stage clinical trials continues to escalate.

This article summarises techniques for formulating poorly water-soluble APIs and how selecting the right outsourcing partner can accelerate development.

Download to read more.

Enter your details below to view the free white paper

By downloading this whitepaper, you acknowledge that GlobalData may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how GlobalData may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Related Content